• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Faster, cheaper test developed for chikungunya virus

Snowy Owl

Retired in 2010, In Memoriam
Faster, cheaper test developed for chikungunya virus

http://www.scidev.net/news/index.cfm?fuseaction=readnews&itemid=3440&language=1

Sanjit Bagchi
23 February 2007
Source: SciDev.Net​
Aedes_aegypti_biting_human_wikipedia.jpg

Chikungunya virus is mainly spread by the Aedes aegypti mosquito

Researchers from Japan and India have developed a rapid and effective test for chikungunya virus that will more suitable for use in developing countries than current diagnostic techniques.

According to research, the new test is not only more sensitive and more specific than current techniques but, crucially for developing countries, is also simpler and more cost-effective.

Chikungunya virus is spread by mosquitoes. It causes high fevers and severe pain in ankle and wrist joints.

The disease affects Africa, India, southeast Asia and the western Pacific.

Outbreaks in India last year affected more than 1.25 million people, according to the World Health Organization.

The RT-LAMP test precisely detects a gene, E1, from the chikungunya virus in body fluid samples from patients.

The test was developed by Manmohan Parida from the Defence Research and Development Establishment, India, with colleagues from Nizam's Institute of Medical Sciences, India, and Nagasaki University, Japan.

The researchers say the test is ten times more sensitive and is more specific for E1 than the current test, RT-PCR. The test correctly identified 21 additional cases that were missed by RT-PCR.

The new test also takes just 30 minutes, whereas RT-PCR needs 3?4 hours. It is cost-effective and simple to perform, since the test does not require high-precision instruments.

Bikram Saha, assistant professor of Medicine at the Midnapore Medical College Hospital, India, agreed that "the currently available techniques have limitations in regard to their implementation in poor developing countries, because these tests work on sophisticated instruments, relatively higher cost and difficult methods".

But the test would have to be further assessed in a larger number of patients before it could be implemented in general practice, he added.

The research was published in the February issue of the Journal of Clinical Microbiology.

Reference: Journal of Clinical Microbiology, 45, 351 (2007)


Related SciDev.Net articles:
Genetic clues to new ferocity of little-known virus

Photo Credit: USDA
 
Back
Top